US Bancorp’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

US Bancorp’s Portfolio CBST Stock Details CBST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-1,445	Closed	-$145K	–	3744
2014 Q4	$145K	Sell	1,445 -1,889	-57%	-$147K	﹤0.01%	1927
2014 Q3	$221K	Sell	3,334 -692	-17%	-$45.5K	﹤0.01%	1705
2014 Q2	$281K	Sell	4,026 -2,902	-42%	-$197K	﹤0.01%	1651
2014 Q1	$507K	Sell	6,928 -499	-7%	-$37.2K	﹤0.01%	1325
2013 Q4	$512K	Sell	7,427 -1,339	-15%	-$86.7K	﹤0.01%	1289
2013 Q3	$557K	Sell	8,766 -959	-10%	-$58K	﹤0.01%	1177
2013 Q2	$469K	Buy	+9,725	New	+$478K	﹤0.01%	1210

US Bancorp's CBST Position: Q1 2015 in Review

US Bancorp sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 1,445 shares — an estimated $145K sold.

US Bancorp first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $557K in Q3 2013. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

US Bancorp reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
US Bancorp sold 1,445 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $145K.
US Bancorp first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
US Bancorp's CUBIST PHARMACEUTICALS INC position peaked at $557K in Q3 2013.
0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on US Bancorp's 13F filing for Q1 2015, filed 8 May 2015.